3Highlights from the 10th World Conference on Lung Cancer[R].Vancouver,Britisha,Canada,August 10-14,2003.In:Clin Lung Cancer,2003,5(3):142.
4FELIPE,STAHELRA,PAVLIDISN.ESMO Minimum Clinical Recommendations for diagnosis,treatment and follow-up of non-small-cell lung cancer(NSCLC)[J].The European Society for Medical Oncology,2005,16(1 Suppl):28-29.
5WANG Jin,QIAO Li-fen,YANG Guang-tian.Role of Shenfu Injection in Rats with Systemic Inflammatory Response Syndrome.Chinese Journal of Integrative Medicine,2008,14(1):51-55.
7Shepherd FA. Chemotherapy for non - small cell lung cancer: have we reached a new plateu [ J]. Semin Oncol, 1999,26( 1 suppl4) :3-11.
8Mazzanti P, Massacesi C, Rocchi MB, et al. Randomized, multicenter, phase Ⅱ study of gemcitabine plus cisplatin versus gemcitabine plus carboplatine in patients with advanced non - small cell lung cancer [ J]. Lung Cancer,2003,41 (1) :81 -87.
9Jassem J, Krzakow SKIN, Roszkow SKIK, et al. A phase Ⅱ study of gemeitabine plus cisplatin in patients with advanced non - small cell lung cancer: clinical outcomes and quality of life [ J ]. Lung Cancer,2002,35:73 - 79.
10Ohe Y, Ohashi Y, Kubota, et al. Randomized phase Ⅲ study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non - small - cell lung cancer: Four - Arm Cooperative Study in Japan[J]. Annals of Oncology, 2007,2,18(2) :317 -323.
